Spectral CT Clinical Trial

Spectral CT Clinical Trial

The objective of this clinical trial was to evaluate the efficacy, ease of operation, stability, and safety of Spectral CT as expected.

Under the premise of protecting subjects and ensuring the scientific nature of this clinical trial, Spectral CT was evaluated for its effectiveness, convenience, stability and safety under normal conditions by collecting clinical cases.

Inclusion Criteria:

• Volunteers (ages 18 to 75);
• Negative pregnancy tests for women of childbearing age;
• Agree to participate in the clinical trial and sign the subject informed consent form;
• Enhanced scan requires laboratory evidence of normal renal function.

Exclusion Criteria:

• The body cannot comply with CT examination;
• Pregnant and lactating women;
• Claustrophobia;
• People who are not suitable for enhanced scanning with iodine contrast agent (previous severe heart failure and hyperthyroidism, iodine contrast agent allergy and susceptibility);
• Patients deemed unsuitable for participation in this clinical trial by the investigator.